US Patent Issued to BLIS TECHNOLOGIES on Nov. 25 for "Antiviral treatment comprising Blis containing probiotic products" (New Zealander Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,089, issued on Nov. 25, was assigned to BLIS TECHNOLOGIES Ltd. (Dunedin, Netherlands).

"Antiviral treatment comprising Blis containing probiotic products" was invented by John David Francis Hale (Dunedin, New Zealand) and John Robert Tagg (Dunedin, New Zealand).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to methods of prophylactically or therapeutically treating viral infections particularly in the lower respiratory tract. Treatment of coronavirus infections is particularly contemplated. The invention also relates to the use of BLIS-producing Streptococcus strains, extracts and exudates thereof, and compositions containing s...